期刊文献+

华蟾素对Raji/ADR细胞多药耐药的逆转作用及机制 被引量:8

Reversal Effect of Cinobufacini on Multidrug Resistance of Raji /ADR Cells and Its Mechanisms
下载PDF
导出
摘要 本研究旨在探讨华蟾素对Raji/ADR细胞多药耐药的逆转作用及其机制。采用MTT法检测华蟾素对Raji及Raji/ADR细胞的生长抑制率、半数抑制浓度(IC50)、逆转阿霉素耐药倍数,并绘制生长抑制率曲线;应用RTPCR法测定MDR-1和MRP-1基因的转录;Western blot法和流式细胞术法测定P-gp、MRP-1蛋白的表达。结果表明:华蟾素对Raji及Raji/ADR细胞72 h增殖抑制率为75.6%和69.3%,IC50分别为3.9 mmol/L和4.6 mmol/L,逆转阿霉素耐药倍数为255.7倍。华蟾素作用于Raji/ADR前后,MDR-1和MRP-1基因转录水平明显下降(P<0.05),P-gp和MRP-1蛋白表达明显降低。结论华蟾素可逆转Raji/ADR细胞对阿霉素的耐药,其机制为通过转录途径下调P-gp和MRP-1蛋白的表达。华蟾素是一种有效的肿瘤多药耐药逆转剂。 The aim of this study was to explore the reversing effect of cinobufacini on multidrug resistance of Raji/ADR cells and its mechanisms.The growth inhibitory rate,half inhibitory concentration (IC50),reversing multiples to adriamycin-resistance were detected by MTT,and the curve of growth inhibitory rate was drawn; the MDR-1 and MRP-1 gene transcription was determined by RT-PCR; the expressions of P-gp and MRP-1 proteins were assayed by Western blot and flow cytometry.The results showed that the inhibitory rates of cinobufacini on Raji and Raji/ADR cells at 72 h were 75.6% and 69.3% respectively,the IC50 were 3.9 mmol/L and 4.6 mmol/L without significant difference (P 〉 0.05).The reversing multiples to adriamycin-resistance were 255.7 multiples,the transcription of mdr-1 and mrp-1 genes and the expression of P-gp and MRP-1 proteins significantly decreased (P 〈 0.05) in Raji/ADR cells after the treatment with cinobufotalin.It is concluded that cinobufotalin can reverse the adriamycin-resistance in Raji/ADR cells and the expression of P-gp and MRP-1 proteins were down-regulated through the transcriptional pathway.The cinobufotalin is an effective reversal agent for the multidrug resistance of tumors.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2014年第5期1306-1310,共5页 Journal of Experimental Hematology
关键词 华蟾素 多药耐药 RAJI细胞 Raji/ADR细胞 阿霉素 cinobufacini multidrug resistance Raji cell Raji/ADR cell adriamycin
  • 相关文献

参考文献3

二级参考文献238

  • 1代丽萍,高慧敏,王智民,王维皓.蟾皮化学成分的分离与结构鉴定[J].药学学报,2007,42(8):858-861. 被引量:41
  • 2LIANG X J, ASZALOS A. Multidrug transporters as drug targets [J].Curr Drug Targets, 2006,7 ( 8 ) : 911 -921.
  • 3SCAGLIOTTI G V, NOVELLO S, SELVAGGI G. Multidrug resistance in non-small-cell lung cancer aquaticus [ J ]. Ann Oncol, 1999,10 (5) : 83 - 86.
  • 4GOTTESMAN M M, FOJO T, BATES S E. Multidrug resistance in cancer: role of ATP-dependent transporters[ J]. Cancer,2002,2( 1 ) :48 -58.
  • 5CHEN C J, CHIN J E, UEDA K, et al. Internal duplication and homology with bacterial transport proteins in the MDR (P-glycoprotein) gene from multidrugresistant human cells [ J ]. Cell, 1986,47 ( 3 ) : 381 - 389.
  • 6HIGGINS C F. ABC transporters:from microorganisms to man[J]. Annu Rev: Cell Biol,1992,8:67 - 113.
  • 7PENA M M O, PUIG S, TH/ELE D J. Characterization of the Saccharomyces cerevisiae high affinity copper transporter Ctr3 [ J ]. J Biol Chem, 2000,275 ( 43 ) : 33244 - 33251.
  • 8SEIKO I,JAEKWON L,DENNIS J T,et al. Uptake of the anticancer drug cisplatin mediated by the cop- per transporter Ctrl in yeast and mammals [ J ]. Proc Natl Acad Sci USA,2002,99(22) :14298 -14302.
  • 9HOLZER A K, HOWELL S B. The internalization and degradation of human copper transporter 1 following cisplatin exposure [ J ]. Cancer Res, 2006,66 (22) :10944 - 10952.
  • 10BRIAN G B R,CHRISTOPHERA L A,ROOHANGIZ S ,et al. Copper transporter 2 regulates the cellular accu- mulation and cytotoxicity of cisplatin and carboplatin [ J ]. Clin Cancer Res,2009,15 ( 13 ) :4312 - 4321.

共引文献77

同被引文献138

引证文献8

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部